Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Major Depressive Disorder · Migraine · AXSM

Axsome Therapeutics

Axsome Therapeutics patent portfolio — 156 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
One World Trade Center, New York, NY 10007, US HQ
2012 Founded
981 Employees
Public company Type
AXSM · NYSE Ticker
Company details
Status
Public
HQ
One World Trade Center, New York, NY 10007, US
Founded
2012
Employees
981
Programs
1
Drugs
8
Patents
156
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Axsome Therapeutics patents

156 pharmaceutical patents indexed for Axsome Therapeutics. 0 expire within 24 months.

Axsome Therapeutics has 156 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

156 patents

Patent portfolio

Page 2 of 4

  1. US 11712441

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11660274

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11648232

    Methods and compositions for treating excessive sleepiness

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11628173

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11617756

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11617791

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11617755

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11607456

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11602563

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11571428

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11560354

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11510927

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11504429

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11471464

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11471465

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11439597

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11433079

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11433035

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11433078

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11426414

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11369684

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11364245

    Use of reboxetine to treat narcolepsy

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11357854

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11351175

    Use of reboxetine to treat narcolepsy

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11344514

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11344513

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11331285

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11331323

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11291639

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11285213

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11285215

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11285214

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11266657

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11219626

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11207327

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11207328

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11185550

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11185547

    Use of reboxetine to treat narcolepsy

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11179352

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11179351

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11135295

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11135226

    Use of reboxetine to treat narcolepsy

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11129895

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11129826

    Bupropion as a modulator of drug activity

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11123344

    Bupropion as a modulator of drug activity

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11123431

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11110173

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11077117

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

156 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.